BERMAN MARK A. (Chief Medical Officer) purchased 16.4% of their position (54.80K shares) of BETTER THERAPEUTICS, INC. on the open market
Open‑market purchase worth $40.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/31/2023ACC: 0000950170-23-035684
Officer· Chief Medical Officer
Since Oct 2021
+54.80K
Net shares
Net buyer
$40.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
54.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+54.80K
Price / share
$0.73
Trade value
$40K
% of position
16.4%
7/27/2023
333.39K→388.19K
Total
Net shares
+54.80K
Net value
$40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/27/2023 | P · Purchase | +54.80K | $0.73 | $40K | 16.4% | 333.39K | 388.19K |
| Total | +54.80K | $40K | ||||||
Derivative Transactions0
No derivative transactions reported